Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline
about
Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccinationProphylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsHuman Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical CancerDegradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicityDegradation of Human PDZ-Proteins by Human Alphapapillomaviruses Represents an Evolutionary Adaptation to a Novel Cellular NichePrevalence of and Risk Factors for Oral Human Papillomavirus Infection among HIV-Positive and HIV-Negative People Who Inject DrugsLow rate of oropharyngeal human papillomavirus infection of women with cervical lesions and their partners: new data from Brazilian population.Genital human papillomavirus infection among women in Bangladesh: findings from a population-based surveyHuman Papilloma Virus' Life Cycle and Carcinogenesis.Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer.The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus.Human papillomavirus type distribution and correlation with cyto-histological patterns in women from the South of ItalyDistribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines.A novel recombinant papillomavirus genome enabling in vivo RNA interference reveals that YB-1, which interacts with the viral regulatory protein E2, is required for CRPV-induced tumor formation in vivoA population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia.Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesionsAge-specific prevalence of human papilloma virus infection among Nigerian womenTherapeutic options for treatment of human papillomavirus-associated cancers - novel immunologic vaccines: ADXS11-001.Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling studyInverse association between methylation of human papillomavirus type 16 DNA and risk of cervical intraepithelial neoplasia grades 2 or 3Rationale and design of the research project of the South Florida Center for the Reduction of Cancer Health Disparities (SUCCESS): study protocol for a randomized controlled trialCo-infection with HPV types from the same species provides natural cross-protection from progression to cervical cancer.The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda.Alternative dosage schedules with HPV virus-like particle vaccines.Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistenceHierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage studyCervical human papillomavirus prevalence and genotype distribution among hybrid capture 2 positive women 15 to 64 years of age in the Gurage zone, rural EthiopiaResidual disease and HPV persistence after cryotherapy for cervical intraepithelial neoplasia grade 2/3 in HIV-positive women in Kenya.Investigating a cluster of vulvar cancer in young women: a cross-sectional study of genital human papillomavirus prevalence.Genotype distribution of human papillomavirus (HPV) in histological sections of cervical intraepithelial neoplasia and invasive cervical carcinoma in Madrid, Spain.DNA methylation profiling across the spectrum of HPV-associated anal squamous neoplasia.Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, GermanyHuman papillomavirus testing in the prevention of cervical cancerPrevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84--results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany.Logistic analysis of epidemiologic studies with augmentation sampling involving re-stratification and population expansionA population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off.Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control studyRisk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults.HPV types and variants among cervical cancer tumors in three regions of Tunisia.Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a meta-analysis of observational studies.
P2860
Q21261267-6064D416-93A5-4315-B582-1958F060263FQ24235373-60B95D22-866D-4D4E-921A-CCCFA5BA22C8Q26799484-C2F7A565-DB7B-499A-8593-1B9888FE49A0Q28475532-B52814CB-8D10-4474-A6F8-F8F6CB289C73Q28548445-E72DC69A-3F10-43D2-BDA3-35A5D6C89A5FQ28551118-D1F17C03-0ECF-403E-9F83-5D0E0BEE70DDQ30850748-4B15257A-80D4-4199-B094-EB59C3D9DE47Q30856793-3CE98E84-D1A8-4FE3-9D69-8A9AA94FD040Q33572600-57EFDBF8-7B1F-42A5-ADC7-662AAC36F370Q33589259-2E6D267E-698C-4847-A069-A31237893F22Q33609914-47124006-FA5E-4FF2-A327-2B8F2066E694Q33633372-96D85E9B-EE22-4E67-A1BC-BDBF416FCEDBQ33708126-40E0ABB2-8F4A-4449-9507-4F4FDA4885A9Q33785593-C2A47484-7535-48E3-88BE-E81DA4D60B7DQ33793914-C12521BC-AFCA-42C5-B5D9-FBB72BE6E2D2Q33830609-3FC85BBC-9E6C-4A7E-BFC6-D365DD52036BQ33890649-4E103CD6-7516-42DD-AE3D-8627D71C34FCQ33908553-1735B01A-6841-44C1-9487-304BBA6542C3Q33930993-75E55ABA-05CC-4FD6-8BDC-604240043C06Q34009689-99E07A64-0F02-4FC7-86B8-F2FC88B693BFQ34022208-079C5AF9-1CD0-4C6B-ACC2-F69B139A040EQ34076719-BE315942-C617-4947-9B00-D38C31786964Q34089666-E9A11C72-2AEF-43EE-B591-9ACFDABBACA4Q34102466-E5C53E1D-38E0-47DD-9E77-8AF12F9D0D2EQ34176414-51119B55-F6B5-4367-B168-9AA9EE7A6CFDQ34268415-C7C8EBE0-63DB-44B0-95E0-9DBB895AF037Q34340212-5810FC5E-D216-4570-BC83-F25A6FFB3DD1Q34400805-E7526E90-C635-48C8-B236-3E9933352CFCQ34435211-6D7D4EC3-EDB5-47CD-B558-288C5D335AD0Q34483573-D3436C61-8B49-4630-8FCF-A988D0747333Q34505483-EF7051A9-BBD7-40C3-A5C1-98EBBBD0F9ABQ34520216-BEA37479-2098-4BB3-86BD-4EDA6C52327CQ34616083-BAE7F64A-74CB-4EE2-9B31-C6E4728914B2Q34622565-4BA0882D-EB63-4FF0-B267-38E45EE768ECQ34678206-5F8C9E5C-2E56-4180-9AAD-19E2CA6572CAQ34789131-A0F0CCD5-0B4A-4A0C-A499-940F4A76DE0BQ34834113-9C6173A2-188B-40AF-A1EE-8DB9A5D9C819Q34882577-D1653FE3-2206-4935-95D4-7A800D39F6F8Q34917796-5CDF92C3-8802-464D-A3CE-A12DA1AB0E17Q34938697-937B260B-06E7-49C6-857C-7DB79CFC5E36
P2860
Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Classification of weakly carci ...... epidemiology at the borderline
@en
Classification of weakly carci ...... pidemiology at the borderline.
@nl
type
label
Classification of weakly carci ...... epidemiology at the borderline
@en
Classification of weakly carci ...... pidemiology at the borderline.
@nl
prefLabel
Classification of weakly carci ...... epidemiology at the borderline
@en
Classification of weakly carci ...... pidemiology at the borderline.
@nl
P2860
P356
P1476
Classification of weakly carci ...... epidemiology at the borderline
@en
P2093
Franco M Buonaguro
Gary Clifford
P2860
P2888
P356
10.1186/1750-9378-4-8
P577
2009-06-01T00:00:00Z
P5875
P6179
1004134036